Development of a VSR correlates with delayed hospital admission after the infarction (> 24 hours) and may be triggered by undue physical activity in the early post infarction period, as well as recurrent ischemia. Risk factors of VSR include age > 60 years, female gender, no history of previous MI and hypertension. 4 The defect is most often at the apical septum in anterior AMI and the base of the heart after inferior AMI, with the orifice varying from 1 to several centimeters in diameter. 5 Early surgical repair has been the only accepted treatment, but it carries very high perioperative mortality and is therefore applied only to selected patients. 6 In recent years, percutaneous closure of postinfarction VSR has been proposed as an alternative to surgical repair and even to the conservative approach. However, experience in percutaneous closure of postinfarction VSR is very limited and restricted to selected patients. 7, 8 The patients treated without surgery mortality is about 90%. Surgical treatment must be carried out on an emergency basis, even if the patient is stable. All VSRs are closed with a patch and associated coronary artery bypass grafting (CABG) operative mortality is 10-15% for anterior defects and 30-35% for posterior defects. 9 We report the case of a 43 years female with postinfarction VSR who was not considered suitable for surgical repair and thus it was treated with percutaneous closure using an Amplatzer device.
Case Summary:
This is the first case of Transcatheter closure of post infarction VSR in Bangladesh using ASD Amplatzer device. A 43 years normotensive diabetic lady admitted in our Hospital with the history of shortness of breath for 07 days. She was diagnosed as a case of anterior AMI with acute left ventricular failure with cardiogenic shock and was treated with Inj. Streptokinase in another cardiac center.
On admission, her Pulse-118/min, BP-90/50 mmHg, a systolic murmur at left lower parasternal region, Lungs-Killip class III crepitation. Transthoracic Echocardiography revealed: severely hypokinetic mid-distal interventricular septum, apex, mid-distal anterior and anteroseptal walls, and moderate LV systolic dysfunction with LVEF: 42% and an echo-dropout about 10 mm seen at distal part of mid antero-septum consistent with VSR.
After admission, she was managed conservatively in CCU. After stabilization, CAG was done which revealed non critical coronary artery disease and Left Ventriculography revealed VSR. Our recommendation was Medical management of IHD and transcatheter closure of VSR.
Technique:
At the beginning of the procedure, the patient was put on mechanical ventilation. The procedure was performed under transesophageal echocardiography guidance. The right femoral artery and right femoral vein were catheterized. An extra stiff Amplatzer wire 0.35 X260 wire was passed through the right femoral artery and inserted at the left ventricle. It was advanced through the VSR to the right ventricle, right atrium and right femoral vein taken by a snare. A 12 mm Amplatzer device was advanced through the wire to the right ventricle and then to the left ventricle. The left side of the device was deployed first at the left ventricle, then the right side at the right ventricle. After confirming its optimal position in the VSR, the device was finally deployed. Left Ventriculography showed a mild persistent left to-right shunt.
The patient's hemodynamics improved and remained stable 24 hours after the procedure then extubated from mechanical ventilation. Transthoracic echocardiography performed the following day showed the Amplatzer device correctly positioned across the VSR and a minor
Conclusion:
Transcatheter device closure is an accepted alternative to surgery for the post-AMI VSR is expanding. Although cardiac surgery with concurrent coronary artery bypass grafting, as indicated, remains the gold standard, a significant proportion of patients are at too high risk for surgery. Transcatheter device closure may provide suitable procedure for noncritical coronary artery disease with suitable lesion. Patients with large residual shunt. After 03 days the patient is discharged with stable hemodynamic condition. The patient is on regular follow-up with complete closure of the residual shunt and normal daily activities. or multiple defects are best treated surgically. A multidisciplinary team, including interventional cardiologists and cardiac surgeons, should evaluate these high-risk patients to determine the optimal management strategy and reduce high morbidity and mortality.
